• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤大小与无功能性胰腺内分泌肿瘤的恶性程度相关。

Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.

机构信息

Department of Surgery, S. Cuore-Don Calabria Hospital, Negrar, Verona, Italy.

出版信息

Surgery. 2011 Jul;150(1):75-82. doi: 10.1016/j.surg.2011.02.022.

DOI:10.1016/j.surg.2011.02.022
PMID:21683859
Abstract

BACKGROUND

Tumor size is a criterion of staging in nonfunctioning pancreatic endocrine tumors as well as a predictor of outcome after curative resection. This study analyzes the correlation between tumor size and malignancy in patients with nonfunctioning pancreatic endocrine tumors.

METHODS

All patients with nonfunctioning pancreatic endocrine tumors who underwent curative resection (R0) at our institution between 1990 and 2008 were considered. Their clinicopathologic characteristics were compared among 3 different groups according to tumor size. Univariate and multivariable analyses were performed.

RESULTS

Over the study period, 177 patients were identified. Overall, 90 patients (51%) had a tumor size ≤2 cm (group 1), 46 (26%) had tumor size between >2 cm and ≤4 cm (group 2), and 41 (23%) had tumor size >4 cm (group 3). Tumors ≤2 cm were more frequently incidentally discovered (group 1, 57% vs group 2, 51% vs group 3, 32%; P = .014) and benign (group 1, 81% vs group 2, 65% vs group 3, 5%; P < .0001). The presence of a nonfunctioning pancreatic endocrine tumor >2 cm and a nonincidental diagnosis of the tumor were independent predictors of malignancy at multivariable analysis. None of the 51 patients (29%) with a pancreatic endocrine tumor ≤2 cm that was incidentally diagnosed died of disease.

CONCLUSION

A strict correlation between tumor size and malignancy in nonfunctioning pancreatic endocrine tumors was demonstrated. A nonoperative management could be advocated for tumors ≤2 cm when discovered incidentally.

摘要

背景

肿瘤大小是非功能性胰腺内分泌肿瘤的分期标准,也是治愈性切除术后预后的预测因素。本研究分析了非功能性胰腺内分泌肿瘤患者的肿瘤大小与恶性程度之间的相关性。

方法

本研究纳入了 1990 年至 2008 年期间在我院接受治愈性切除(R0)的所有非功能性胰腺内分泌肿瘤患者。根据肿瘤大小将其分为 3 组,比较各组患者的临床病理特征。进行单因素和多因素分析。

结果

研究期间共发现 177 例患者。总体而言,90 例(51%)患者肿瘤大小≤2cm(组 1),46 例(26%)肿瘤大小在>2cm 至≤4cm 之间(组 2),41 例(23%)肿瘤大小>4cm(组 3)。肿瘤≤2cm 更常为偶然发现(组 1,57%比组 2,51%比组 3,32%;P=0.014),且多为良性(组 1,81%比组 2,65%比组 3,5%;P<0.0001)。肿瘤>2cm 且为非偶然诊断是非功能性胰腺内分泌肿瘤恶性的独立预测因素。在多因素分析中,51 例偶然发现且肿瘤大小≤2cm 的患者中无 1 例死于该病。

结论

本研究证实了非功能性胰腺内分泌肿瘤中肿瘤大小与恶性程度之间存在严格的相关性。对于偶然发现的≤2cm 的肿瘤,可以提倡非手术治疗。

相似文献

1
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.肿瘤大小与无功能性胰腺内分泌肿瘤的恶性程度相关。
Surgery. 2011 Jul;150(1):75-82. doi: 10.1016/j.surg.2011.02.022.
2
[Non-functioning tumors of the endocrine pancreas. Concept, diagnosis, treatment].[胰腺内分泌无功能肿瘤。概念、诊断、治疗]
J Chir (Paris). 1990 Apr;127(4):185-90.
3
Protocol for the examination of specimens from patients with endocrine tumors of the pancreas, including those with mixed endocrine and acinar cell differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists.胰腺内分泌肿瘤患者标本检查方案,包括那些具有内分泌和腺泡细胞混合分化的患者:检查表的基础。美国病理学家学会癌症委员会
Arch Pathol Lab Med. 2000 Jan;124(1):30-6. doi: 10.5858/2000-124-0030-PFTEOS.
4
Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.用于胰腺内分泌肿瘤预后评估的改良组织学和临床病理标准
Hum Pathol. 2009 Jan;40(1):30-40. doi: 10.1016/j.humpath.2008.06.005. Epub 2008 Aug 20.
5
Support for a postresection prognostic score for pancreatic endocrine tumors.支持建立用于预测胰腺内分泌肿瘤术后的预后评分。
Am J Surg. 2011 Mar;201(3):406-10; discussion 410. doi: 10.1016/j.amjsurg.2010.09.023.
6
[Management of nonfunctioning islet cell tumors of the pancreas].[胰腺无功能胰岛细胞瘤的管理]
Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):457-60.
7
[Endocrine tumors of the pancreas. Review of 30 years of research].
Pathologica. 1998 Jun;90(3):215-21.
8
Endoscopic ultrasonography of nonfunctioning pancreatic islet cell tumors with histologic correlation.无功能性胰岛细胞瘤的内镜超声检查及其组织学相关性
Hepatogastroenterology. 2004 Nov-Dec;51(60):1590-4.
9
Surgical treatment of nonfunctioning islet cell tumor: report of 41 cases.无功能性胰岛细胞瘤的外科治疗:41例报告
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):469-72.
10
Islet Tumors: Resect or Follow?胰岛肿瘤:切除还是观察?
Adv Surg. 2020 Sep;54:69-88. doi: 10.1016/j.yasu.2020.04.004. Epub 2020 Jun 17.

引用本文的文献

1
The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images.人工智能和深度学习在利用超声内镜(EUS)图像确定胰腺神经内分泌肿瘤组织病理学分级中的作用。
Endosc Ultrasound. 2025 Mar-Apr;14(2):48-56. doi: 10.1097/eus.0000000000000113. Epub 2025 May 2.
2
Pancreatic Neuroendocrine Diagnostic Imaging Order and Reader Evaluation over Two Decades in a Tertiary Academic Center.二十年来在一家三级学术中心进行的胰腺神经内分泌诊断成像检查及阅片评估
Diagnostics (Basel). 2025 Apr 10;15(8):960. doi: 10.3390/diagnostics15080960.
3
Development and validation of a CT-based nomogram to preoperative prediction of pancreatic neuroendocrine tumors (pNETs) grade.
基于CT的列线图用于术前预测胰腺神经内分泌肿瘤(pNETs)分级的开发与验证。
Abdom Radiol (NY). 2025 Apr 28. doi: 10.1007/s00261-025-04959-z.
4
Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumors.观察性与切除性胰腺神经内分泌肿瘤的特征及预后
Proc (Bayl Univ Med Cent). 2025 Feb 18;38(3):213-219. doi: 10.1080/08998280.2025.2463289. eCollection 2025.
5
Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的外科治疗
Cancers (Basel). 2025 Jan 23;17(3):377. doi: 10.3390/cancers17030377.
6
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.淋巴结阴性胰腺神经内分泌肿瘤中淋巴管侵犯的发生率及预后意义:美国神经内分泌研究组的结果
J Surg Oncol. 2025 Mar;131(3):465-472. doi: 10.1002/jso.27914. Epub 2024 Oct 13.
7
Portuguese Pancreatic Club Perspective on the Surveillance Strategy for Pancreatic Neuroendocrine Tumours: When and How to Do It?葡萄牙胰腺俱乐部关于胰腺神经内分泌肿瘤监测策略的观点:何时以及如何进行监测?
GE Port J Gastroenterol. 2024 Jan 16;31(5):306-313. doi: 10.1159/000535815. eCollection 2024 Oct.
8
Portuguese Pancreatic Club Perspectives on Endoscopic Ultrasound-Guided and Surgical Treatment of Pancreatic Neuroendocrine Tumors.葡萄牙胰腺俱乐部对胰腺神经内分泌肿瘤的内镜超声引导治疗和手术治疗的观点
GE Port J Gastroenterol. 2023 Oct 30;31(4):225-235. doi: 10.1159/000534032. eCollection 2024 Aug.
9
Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.立体定向体部放疗治疗小胰腺神经内分泌肿瘤的前瞻性研究:耐受性与疗效分析
Clin Transl Oncol. 2025 Jan;27(1):377-385. doi: 10.1007/s12094-024-03538-w. Epub 2024 Jun 22.
10
Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?胰腺神经内分泌肿瘤:最佳手术选择是什么?
J Clin Med. 2024 May 20;13(10):3015. doi: 10.3390/jcm13103015.